Implantable Cardioverter Defibrillator in Arrhythmogenic Cardiomyopathy

Cardiac Electrophysiology Clinics

Volumn 3, Issue 2, 2011, Pages 311-321

  Corrado, Domenico ^a   Silvano, Maria ^a   Migliore, Federico ^a   Marinelli, Alessio ^a   Leoni, Loira ^a   Thiene, Gaetano ^a   Iliceto, Sabino ^a   Buja, Gianfranco ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Arrhythmogenic right ventricular cardiomyopathy dysplasia; Implantable cardioverter defibrillator; Sudden cardiac death; Therapy Ventricular fibrillation

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; SOTALOL;

CONGESTIVE HEART FAILURE; CONVULSIVE THERAPY; DEFIBRILLATOR; DEVICE SAFETY; ELECTROCARDIOGRAM; ENDOCARDITIS; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; PRIORITY JOURNAL; PROSTHESIS FAILURE; REVIEW; SUDDEN DEATH;

EID: 79954606144     PISSN: 18779182     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccep.2011.02.003     Document Type: Review

References (28)

1. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996, 335:1933-1940.
2. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997, 337:1576-1583.
3. Buxton A.E., Lee K.L., Fisher J.D., et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999, 341:1882-1890.
4. Marcus F.I., Fontaine G., Guiraudon G., et al. Right ventricular dysplasia. A report of 24 adult cases. Circulation 1982, 65:384-398.
5. Thiene G., Nava A., Corrado D., et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988, 318:129-133.
6. Basso C., Thiene G., Corrado D., et al. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis?. Circulation 1996, 94:983-991.
7. Corrado D., Basso C., Thiene G., et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol 1997, 30:1512-1520.
8. Corrado D., Basso C., Thiene G. Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment. Heart 2000, 83:588-595.
9. Basso C., Corrado D., Marcus F.I., et al. Arrhythmogenic right ventricular cardiomyopathy. Lancet 2009, 373:1289-1300.
10. Corrado D., Basso C., Thiene G. Arrhythmogenic right ventricular cardiomyopathy: an update. Heart 2009, 95:766-773.
11. Corrado D., Leoni L., Link M.S., et al. Implantable cardioverter defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2003, 108:3084-3091.
12. Corrado D., Calkins H., Link M.S., et al. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Circulation 2010, 122:1144-1152.
13. McKenna W.J., Sen-Chowdhry S., Maron B.J. The cardiomyopathies. Sudden cardiac death. A handbook for clinical practice 2006, Backwell Publishing, Oxford (UK), p. 109-31. S.G. Priori, D.P. Zipes (Eds.).
14. Blomstrom-Lundqvist C., Sabel C.G., Olsson S.B. Long term follow-up of 15 patients with arrhythmogenic right ventricular dysplasia. Br Heart J 1987, 58:477-488.
15. Nava A., Bauce B., Basso C., et al. Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2000, 36:2226-2233.
16. Hulot J.S., Jouven X., Empana J.P., et al. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 2004, 110:1879-1884.
17. Corrado D., Thiene G. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: clinical impact of molecular genetic studies. Circulation 2006, 113:1634-1637.
18. Corrado D., Basso C., Pilichou K., et al. Molecular biology and the clinical management of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart 2011, 97:530-539.
19. Breithardt G., Wichter T., Haverkamp W., et al. Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease. Am Heart J 1994, 127:1151-1158.
20. Link M., Wang P.J., Haugh C.J., et al. Arrhythmogenic right ventricular dysplasia: clinical results with implantable cardioverter defibrillator. J Intervent Card Electrophysiol 1997, 1:41-48.
21. Tavernier R., Gevaert S., de Sutter J., et al. Long term results of cardioverter defibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias. Heart 2001, 85:53-56.
22. Wichter T., Paul M., Wollmann C., et al. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. Circulation 2004, 109:1503-1508.
23. Roguin A., Bomma C.S., Nasir K., et al. Implantable cardioverter defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2004, 43:1843-1852.
24. Hodgkinson K.A., Parfrey P.S., Basset A.S., et al. The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). J Am Coll Cardiol 2005, 45:400-408.
25. Merner N.D., Hodgkinson K.A., Haywood A.F., et al. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am J Hum Genet 2008, 82:809-821.
26. Maron B.J., Shen W.K., Link M.S., et al. Efficacy of implantable cardioverter-ICDs for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000, 342:365-373.
27. Brugada J., Brugada R., Antzelevitch C., et al. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002, 105:73-78.
28. Schwartz P.J., Spazzolini C., Priori S.G., et al. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry. Circulation 2010, 122:1272-1282.